Ligand binding and aggregation of pathogenic SOD1

Nature Communications

Volumn 4, Issue , 2013, Pages

  Wright, Gareth S A ^a   Antonyuk, Svetlana V ^a   Kershaw, Neil M ^a   Strange, Richard W ^a   Samar Hasnain, S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FLUOROURIDINE; ISOPRENALINE; 5-FLUOROURIDINE; ADRENALIN; APOPROTEIN; DOPAMINE; GUANIDINE; LIGAND; MUTANT PROTEIN; PROTEIN BINDING; RECOMBINANT PROTEIN; SUPEROXIDE DISMUTASE; URIDINE;

DISEASE TREATMENT; ENZYME ACTIVITY; GENE EXPRESSION; LIGAND; MUTATION; PATHOLOGY; PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITION; ENZYME STABILITY; LIGAND BINDING; PROTEIN AGGREGATION; ANALOGS AND DERIVATIVES; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MUTATION; PROTEIN MULTIMERIZATION; PROTEIN QUATERNARY STRUCTURE; PROTEIN UNFOLDING; SMALL ANGLE SCATTERING; X RAY DIFFRACTION;

APOPROTEINS; DOPAMINE; ENZYME STABILITY; EPINEPHRINE; GUANIDINE; HUMANS; ISOPROTERENOL; LIGANDS; MODELS, MOLECULAR; MUTANT PROTEINS; MUTATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN UNFOLDING; RECOMBINANT PROTEINS; SCATTERING, SMALL ANGLE; SUPEROXIDE DISMUTASE; URIDINE; X-RAY DIFFRACTION;

EID: 84877751338     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2750     Document Type: Article

References (60)

1. Mitchell, J. D. & Borasio, G. D. Amyotrophic lateral sclerosis. Lancet 369, 2031-2041 (2007).
2. Traynor, B. J. et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: a population-based study. Arch. Neurol. 57, 1171-1176 (2000). (Pubitemid 30644664)
3. Rosen, D. R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62 (1993). (Pubitemid 23087289)
4. Wroe, R., Wai-Ling Butler, A., Andersen, P. M., Powell, J. F. & Al-Chalabi, A. ALSOD: the amyotrophic lateral sclerosis online database. Amyotroph. Lateral Scler. 9, 249-250 (2008).
5. Radunovíc, A. & Leigh, P. N. Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features. J. Neurol. Neurosurg. Psychiatr. 61, 565-572 (1996). (Pubitemid 27023331)
6. Cleveland, D. W., Laing, N., Hurse, P. V. & Brown, R. H. Toxic mutants in Charcot's sclerosis. Nature 378, 342-343 (1995).
7. Zinman, L. et al. A mechanism for low penetrance in an ALS family with a novel SOD1 deletion. Neurology 72, 1153-1159 (2009).
8. Sapp, P. C. et al. Identification of three novel mutations in the gene for Cu/Zn superoxide dismutase in patients with familial amyotrophic lateral sclerosis. Neuromuscul. Disord. 5, 353-357 (1995).
9. Shaw, P. J. et al. CNS tissue Cu/Zn superoxide dismutase (SOD1) mutations in motor neurone disease (MND). Neuroreport 8, 3923-3927 (1997). (Pubitemid 28027210)
10. Shi, S., Li, L., Chen, K. & Liu, X. Identification of the mutation of SOD1 gene in a familial amyotrophic lateral sclerosis. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21, 149-152 (2004). (Pubitemid 38506626)
11. Wang, J., Xu, G. & Borchelt, D. R. High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation. Neurobiol. Dis. 9, 139-148 (2002). (Pubitemid 34261210)
12. Kato, S. et al. New consensus research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 (SOD1) gene mutations: inclusions containing SOD1 in neurons and astrocytes. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 163-184 (2000).
13. Prudencio, M., Hart, P. J., Borchelt, D. R. & Andersen, P. M. Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum. Mol. Genet. 18, 3217-3226 (2009).
14. Münch, C. & Bertolotti, A. Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants. J. Mol. Biol. 399, 512-525 (2010).
15. Vassall, K. A. et al. Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS. Proc. Natl Acad. Sci. USA 108, 2210-2215 (2011).
16. Wang, Q., Johnson, J. L., Agar, N. Y. & Agar, J. N. Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival. PLoS Biol. 6, 1508-1526 (2008).
17. Ray, S. S. et al. An intersubunit disulfide bond prevents in vitro aggregation of a superoxide dismutase-1 mutant linked to familial amytrophic lateral sclerosis. Biochemistry 43, 4899-4905 (2004). (Pubitemid 38544443)
18. Auclair, J. R., Boggio, K. J., Petsko, G. A., Ringe, D. & Agar, J. N. Strategies for stabilizing superoxide dismutase (SOD1), the protein destabilized in the most common form of familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 107, 21394-21399 (2010).
19. Khare, S. D., Caplow, M. & Dokholyan, N. V. The rate and equilibrium constants for a multistep reaction sequence for the aggregation of superoxide dismutase in amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 101, 15094-15099 (2004). (Pubitemid 39391724)
20. Ray, S. S. & Lansbury, P. T. A possible therapeutic target for Lou Gehrig's disease. Proc. Natl Acad. Sci. USA 101, 5701-5702 (2004). (Pubitemid 38520465)
21. Ray, S. S., Nowak, R. J., Brown, R. H. & Lansbury, P. T. Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation. Proc. Natl Acad. Sci. USA 102, 3639-3644 (2005). (Pubitemid 40354664)
22. Nowak, R. J., Cuny, G. D., Choi, S., Lansbury, P. T. & Ray, S. S. Improving binding specificity of pharmacological chaperones that target mutant superoxide dismutase-1 linked to familial amyotrophic lateral sclerosis using computational methods. J. Med. Chem. 53, 2709-2718 (2010).
23. Hough, M. A. et al. Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc. Natl Acad. Sci. USA 101, 5976-5981 (2004). (Pubitemid 38520513)
24. David, G. & Perez, J. Combined sampler robot and high-performance liquid chromatography: a fully automated system for biological small-angle X-ray scattering experiments at the Synchrotron SOLEIL SWING beamline. J. Appl. Cryst. 42, 892-900 (2009).
25. Wright, G. S. A., Hasnain, S. S. & Grossmann, J. G. The structural plasticity of the human copper chaperone for SOD1: insights from combined size-exclusion chromatographic and solution X-ray scattering studies. Biochem. J. 439, 39-44 (2011).
26. Arnesano, F. et al. The unusually stable quaternary structure of human Cu, Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status. J. Biol. Chem. 279, 47998-48003 (2004). (Pubitemid 39540952)
27. Juneja, T., Pericak-Vance, M. A., Laing, N. G., Dave, S. & Siddique, T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu, Zn superoxide dismutase. Neurology 48, 55-57 (1997). (Pubitemid 27039517)
28. Fischer, H., de Oliveira Neto, M., Napolitano, H. B., Polikarpov, I. & Craievich, A. F. Determination of the molecular weight of proteins in solution from a single small-angle X-ray scattering measurement on a relative scale. J. Appl. Cryst. 43, 101-109 (2009).
29. Rakhit, R. et al. Monomeric Cu, Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J. Biol. Chem. 279, 15499-15504 (2004). (Pubitemid 38618950)
30. Banci, L. et al. SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization. PLoS ONE 3, e1677 (2008).
31. Banci, L. et al. Interaction of cisplatin with human superoxide dismutase. J. Am. Chem. Soc. 134, 7009-7014 (2012).
32. Rodriguez, J. A. et al. Familial amyotrophic lateral sclerosis-associated mutations decrease the thermal stability of distinctly metallated species of human copper/zinc superoxide dismutase. J. Biol. Chem. 277, 15932-15937 (2002). (Pubitemid 34967874)
33. Kelly, S. M. & Price, N. C. The application of circular dichroism to studies of protein folding and unfolding. Biochim. Biophys. Acta 1338, 161-185 (1997). (Pubitemid 27156998)
34. Kayatekin, C., Zitzewitz, J. A. & Matthews, C. R. Zinc binding modulates the entire folding free energy surface of human Cu, Zn superoxide dismutase. J. Mol. Biol. 384, 540-555 (2008).
35. Antonyuk, S., Strange, R. W. & Hasnain, S. S. Structural discovery of small molecule binding sites in Cu-Zn human superoxide dismutase familial amyotrophic lateral sclerosis mutants provides insights for lead optimization. J. Med. Chem. 53, 1402-1406 (2010).
36. Congreve, M., Carr, R., Murray, C. & Jhoti, H. A 'rule of three' for fragment-based lead discovery? Drug. Discov. Today 8, 876-877 (2003). (Pubitemid 37194496)
37. Liang, Y. et al. Endogenous sulfur dioxide protects against isoproterenol-induced myocardial injury and increases myocardial antioxidant capacity in rats. Lab. Invest. 91, 12-23 (2010).
38. Banci, L. et al. Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: a possible general mechanism for familial ALS. Proc. Natl Acad. Sci. USA 104, 11263-11267 (2007). (Pubitemid 47175129)
39. Schmidlin, T., Kennedy, B. K. & Daggett, V. Structural changes to monomeric CuZn superoxide dismutase caused by the familial amyotrophic lateral sclerosis-associated mutation A4V. Biophys. J. 97, 1709-1718 (2009).
40. Molnar, K. S. et al. A common property of amyotrophic lateral sclerosis-associated variants: destabilization of the copper/zinc superoxide dismutase electrostatic loop. J. Biol. Chem. 284, 30965-30973 (2009).
41. Durazo, A. et al. Metal-free superoxide dismutase-1 and three different amyotrophic lateral sclerosis variants share a similar partially unfolded beta-barrel at physiological temperature. J. Biol. Chem. 284, 34382-34389 (2009).
42. Taylor, D. M. et al. Tryptophan 32 potentiates aggregation and cytotoxicity of a copper/zinc superoxide dismutase mutant associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 282, 16329-16335 (2007). (Pubitemid 47100349)
43. Zhang, H., Andrekopoulos, C., Joseph, J., Crow, J. & Kalyanaraman, B. The carbonate radical anion-induced covalent aggregation of human copper, zinc superoxide dismutase, and alpha-synuclein: intermediacy of tryptophan-and tyrosine-derived oxidation products. Free. Radic. Biol. Med. 36, 1355-1365 (2004). (Pubitemid 38596795)
44. Grad, L. I. et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc. Natl Acad. Sci. USA 108, 16398-16403 (2011).
45. Furukawa, Y., Kaneko, K., Yamanaka, K. & Nukina, N. Mutation-dependent polymorphism of Cu, Zn-superoxide dismutase aggregates in the familial form of amyotrophic lateral sclerosis. J. Biol. Chem. 285, 22221-22231 (2010).
46. Maurer-Stroh, S. et al. Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat. Methods 7, 237-242 (2010).
47. Oliveberg, M. Waltz, an exciting new move in amyloid prediction. Nat. Methods 7, 187-188 (2010).
48. Kershaw, N. K. et al. X-ray crystallography and computational docking for the detection and development of protein-ligand interactions. Curr. Med. Chem. 20, 569-575 (2013).
49. McCord, J. M. & Fridovich, I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244, 6049-6055 (1969).
50. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997). (Pubitemid 27085611)
51. Kabsch, W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr. D 66, 133-144 (2010).
52. Battye, T. G. G., Kontogiannis, L., Johnson, O., Powell, H. R. & Leslie, A. G. W. iMOSFLM: A new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr. D 67, 271-281 (2011).
53. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760-763 (1994).
54. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240-255 (1997). (Pubitemid 27235885)
55. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (2004). (Pubitemid 41742764)
56. Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J. & Svergun, D. I. PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J. Appl. Cryst. 36, 1277-1282 (2003).
57. Svergun, D. I. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Cryst 25, 495-503 (1992). (Pubitemid 23564996)
58. Svergun, D. I., Petoukhov, M. V. & Koch, M. H. Determination of domain structure of proteins from X-ray solution scattering. Biophys. J. 80, 2946-2953 (2001). (Pubitemid 32521666)
59. Volkov, V. & Svergun, D. Uniqueness of ab initio shape determination in small-angle scattering. J. Appl. Cryst. 36, 860-864 (2003).
60. Wright, G. S. A. et al. The application of hybrid pixel detectors for in-house SAXS instrumentation with a view to combined chromatographic operation. J. Synchrotron Radiat. 20, 383-385 (2013).